openPR Logo
Press release

Retinal Surgery Devices Market Regulations and Competitive Landscape Outlook to 2020

02-23-2017 02:21 PM CET | IT, New Media & Software

Press release from: TMR - Research Reports

Retinal Surgery Devices Market Regulations and Competitive

Retinal surgery devices are undergoing rapid technological advancement to establish an effective treatment platform for various retinal diseases. For instance, minimally invasive surgical instruments for the treatment of retinal diseases offer advantages such as lesser pain, minor scarring, quick recovery and reduced health care costs. Applications of retinal surgery devices across various ophthalmic conditions such as diabetic retinopathy, retinal detachment, epiretinal membrane and macular hole are driving the growth of the global retinal surgery devices market. Furthermore, increasing geriatric population is fueling the growth of the market, as these individuals are reported to be at a higher risk of developing eye-related disorders.

Obtain the Sample Containing Upcoming Market Trends of Retinal Surgery Devices at: http://www.transparencymarketresearch.com/sample/sample.php?flag=S&rep_id=4152

In terms of type of equipment, the retinal surgery devices market has been segmented into vitrectomy packs, vitrectomy machines, retinal laser equipment, microscopic illumination equipment, surgical instruments and others (retinal tamponades, sclera buckle, etc.) Vitrectomy packs accounted for the largest share of the retinal surgery devices market in terms of revenue in 2013. The segment is expected to grow at the highest CAGR during the forecast period from 2014 to 2020. Factors that contribute to the high growth of vitrectomy packs segment are increased timesaving during and after the retinal surgery procedure by cutting back on the preparation time and the growing demand for single-use sterile packs of surgical instruments in order to cut costs through better inventory management.

Based on applications, the retinal surgery devices market has been segmented into diabetic retinopathy, retinal detachment, epiretinal membrane, macular hole and other applications that include eye infections and eye injuries. The diabetic retinopathy application segment held the largest share of the retinal surgery devices market in 2013 due to high prevalence of diabetic retinopathy across the globe and growing patient preference to opt for retinal surgery as their first treatment option for long-term benefit. However, the retinal detachment application segment is anticipated to grow at the highest CAGR during the forecast period from 2014 to 2020. Factors attributed to the growth of the segment are increasing geriatric population and severe ophthalmic ailments affecting them such as formation of scar tissue on the retina and retinal tear. In addition, retinal surgery offers better results in the treatment of retinal detachment, which boosts the growth of the segment.

Geographically, North America was the largest market for retinal surgery devices in 2013. Factors driving the growth of the retinal surgery devices market in North America are increasing prevalence of eye diseases among the geriatric and diabetic population. According to recent data from the U.S. Centers for Disease Control and Prevention (CDC) in 2014, around 26 million people in the U.S. have diabetes, and over 28% of diabetics aged 40 years and above have diabetic retinopathy and related diabetic eye diseases. Furthermore, technological developments in the field of ophthalmic surgical devices and increasing awareness of the population about surgical treatments of various retinal diseases are boosting the growth of the retinal surgery devices market in North America. However, Asia Pacific is likely to record the highest CAGR during the forecast period. Large population base, greater initiatives taken by the governments to promote health care and robust economic growth are the factors attributed to the high growth in the region. Moreover, improving consumer awareness about eye care and better disease management would drive the growth of the retinal surgery devices market in Asia Pacific.

Read the Current Market Status of Retinal Surgery Devices at: http://www.transparencymarketresearch.com/retinal-surgery-devices-market.html

The global retinal surgery devices market is fragmented due to the presence of well established as well as emerging companies in this field. The top companies operating in the retinal surgery devices market are Bausch + Lomb Incorporated, Synergetics, Inc., IRIDEX Corporation, Alcon, Inc., Carl Zeiss Meditec AG, Leica Microsystems, NIDEK CO., LTD., Topcon Corporation, Lumenis, and Optos plc.

Transparency Market Research (TMR) is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. TMR’s experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather and analyze information.

Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.

90 State Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA - Canada Toll Free: 866-552-3453
Email: sales@transparencymarketresearch.com
Website: http://www.transparencymarketresearch.com/

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Retinal Surgery Devices Market Regulations and Competitive Landscape Outlook to 2020 here

News-ID: 447081 • Views:

More Releases from TMR - Research Reports

Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2024
Pulmonary Drugs Market is Expected to Reach US$ 28,082.1 Million by the End of 2 …
According to the research report, the global pulmonary drugs market is expected to be worth US$ 28,082.1 mn by the end of 2024 as compared to US$ 48,039.7 mn in 2015. Analysts calculate that the global market will plummet at a CAGR of -6.3% during the forecast period of 2016 and 2024. The market will thrive as the demand for combination drugs is anticipated to remain on the rise during
North America Ventricular Assist Device Market is rising to a valuation of US$ 1.07 Billion by 2024
North America Ventricular Assist Device Market is rising to a valuation of US$ 1 …
According to TMR, the opportunity in the North America market for VADs, which stood at US$0.4 bn in 2015, is likely to expand at a healthy CAGR of 9.20% between 2016 and 2024 and increase to US$1.07 bn by the end of the forecast period. The destination therapy (DT) segment has been reporting a greater application of VADs than the other two indication segments. It is expected to remain the
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million by 2024
Dental Membrane and Bone Graft Substitutes Market to rise to US$ 922.6 Million b …
Transparency Market Research notes that innovation and expansion into emerging regions have served these companies well in strengthening their hold in the dental membrane and bone graft substitutes market. For instance, Switzerland-based Geistlich Pharma AG - a global manufacturer and supplier of dental products and devices - expanded its operations in Sydney, Australia and New Delhi, India in 2016. The global dental membrane and bone graft substitutes market is expected to
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
Human Vaccines Market is Estimated to Reach US$ 72.5 Billion by 2024
The global human vaccines market was valued at US$28.3 bn in 2015 and is estimated to reach US$72.5 bn by 2024, registering an 11.2% CAGR during the forecast period. By age group, pediatric vaccines accounted for a 57.5% share in the global human vaccines market in 2015. Adult vaccines, on the other hand, are expected to expand at a 13.2% CAGR from 2016 to 2024. Based on product, the pneumococcal segment

All 5 Releases


More Releases for Retinal

Retinal Vein Occlusion Market : Information by Type (Branch Retinal Artery Occlu …
Retinal vein occlusion (RVO) causes permanent blindness. It is dominant in the geriatric population. However, it can also be found in people with leukemia, glaucoma, lymphoma, and multiple myeloma. Retinal vein occlusion is broadly categorized into central retinal artery occlusion (CRAO) and branch retinal vein occlusion (BRVO). Glaucoma is another such condition that damages optic nerves and causes retinal vein occlusion, which is becoming another point of concern across
What's driving the Retinal Implants Market Growth? Prominent Players: Second Sig …
An analysis of Retinal Implants market has been provided in the latest report added by Market Study Report that primarily focuses on the market trends, demand spectrum, and future prospects of this industry over the forecast period. Furthermore, the report provides a detailed statistical overview in terms of trends outlining the geographical opportunities and contributions by prominent industry share contenders. The global Retinal Implants market is valued at million
Retinal Implants Sales Market Analysis By Top Players - Second Sight Medical Pro …
Worldwide Market Reports has announced the addition of the “Global Retinal Implants Market Size Status and Forecast 2022”, The report classifies the global Retinal Implants Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. Global Retinal Implants market competition by top manufacturers/players, with Retinal Implants sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player;
Retinal Implants Sales Market Analysis By Top Players - Second Sight Medical Pro …
Worldwide Market Reports has announced the addition of the “Global Retinal Implants Market Size Status and Forecast 2022”, The report classifies the global Retinal Implants Market in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. Global Retinal Implants market competition by top manufacturers/players, with Retinal Implants sales volume, Price (K USD/Unit), revenue (Million USD) and market share for each manufacturer/player;
Global Retinal Implants Market 2018 - Centrasight, Retinal Implant, Boston Retin …
Eminent Market Reports, recently published a detailed market research study focused on the “Retinal Implants Market” across the global, regional and country level. The report provides 360° analysis of “Retinal Implants Market” from view of manufacturers, regions, product types and end industries. The research report analyses and provides the historical data along with current performance of the global PP Pipe industry, and estimates the future trend of Retinal Implants on
Retinal Surgery Device Market, Global Forecast by Segments (Retinal Lasers, Vitr …
Renub Research report titled “Retinal Surgery Device Market, Global Forecast by Segments (Retinal Lasers, Vitrectomy Machines, Instruments, Tamponades, Retinal Laser Probes, Hemostasis, Light Pipes, Cryosurgery, Vitrectomy Packs, and Light source & others.) Companies (Alcon Laboratories, Inc., Carl Zeiss, Topcon Corporation, Valeant Pharmaceutical International Inc., Iridex Coporation, Ellex Medical Lasers, Escalon Medical, and Second Sight Medical Products Inc.)” studies the global retinal surgery device market. This 85 page report with 42